Sheng Hu - Hubei Cancer Hospital, Wuhan, 430079, China

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 129 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Toripalimab Plus Chemotherapy As a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: the Phase 3 EXTENTORCH Randomized Clinical Trial

Ying Cheng,Wei Zhang,Lin Wu,Caicun Zhou,Donglin Wang, Bing Xia,Minghong Bi,Xiuhua Fu,Chong Li,Dongqing Lv,Yanqiu Zhao,Gongyan Chen,Tienan Yi,Jianan Huang,Min Li,Runxiang Yang, Xiaoping Huang,Ye Wang,Mingjun Zhang,Yueyin Pan,Yilan Sun,Sheng Hu,Xiqin Zhang, Min Zhou,Jian Fang,Faguang Jin,Yunpeng Liu,Yinyin Li,Zhihong Zhang,Jie Hu,Laiyu Liu,Rui Wang, Yan Li,Kangsheng Gu, Cuimin Ding,Qingxia Fan,Guojun Zhang,Yongxing Chen,Liyan Jiang,Wei-E Zheng,Shaoshui Chen,Cheng Huang,Zhigang Han, Hong Yang, Jianfang Wang, Baocheng Wang,Huita Wu,Yongxing Bao,Manxiang Li, Xianming Luo, Shanshan Gu, Wenbo Yu, Kai Xu, Simo Zhang, Jianjun Yu

JAMA oncology（2024）

引用0浏览0WOS引用

Toripalimab Plus Chemotherapy As a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer

Ying Cheng,Wei Zhang,Lin Wu,Caicun Zhou,Donglin Wang, Bing Xia,Minghong Bi, Xiuhua Fu, Chong Li,Dongqing Lv, Yanqiu Zhao,Gongyan Chen, Tienan Yi,Jianan Huang,Min Li,Runxiang Yang, Xiaoping Huang, Ye Wang,Mingjun Zhang,Yueyin Pan,Yilan Sun,Sheng Hu,Xiqin Zhang, Min Zhou,Jian Fang,Faguang Jin,Yunpeng Liu,Yinyin Li,Zhihong Zhang,Jie Hu,Laiyu Liu,Rui Wang,Yan Li,Kangsheng Gu, Cuimin Ding,Qingxia Fan,Guojun Zhang,Yongxing Chen,Liyan Jiang,Wei-E. Zheng,Shaoshui Chen,Cheng Huang,Zhigang Han, Hong Yang, Jianfang Wang, Baocheng Wang,Huita Wu,Yongxing Bao,Manxiang Li, Xianming Luo, Shanshan Gu, Wenbo Yu, Kai Xu, Simo Zhang, Jianjun Yu

JAMA Oncology (2024)

引用0浏览0引用

A Plain Language Summary of Results from the CHOICE-01 Trial of Toripalimab Plus Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)

Zhijie Wang,Lin Wu,Baolan Li,Ying Cheng,Xiaoling Li, Xicheng Wang,Liang Han,Xiaohong Wu, Yun Fan,Yan Yu, Dongqing Lv,Jianhua Shi,Jianjin Huang,Shaozhang Zhou,Baohui Han,Guogui Sun,Qisen Guo,Youxin Ji,Xiaoli Zhu,Sheng Hu,Wei Zhang,Qiming Wang, Yuming Jia,Ziping Wang,Yong Song,Jingxun Wu,Meiqi Shi,Xingya Li, Zhigang Han, Yenpeng Liu, Zhuang Yu,An-Wen Liu,Xiuwen Wang,Caicun Zhou,Diansheng Zhong,Liyun Miao, Zhihong Zhang,Hui Zhao,Jun Yang,Dong Wang, Yingyi Wang,Qiang Li,Xiaodong Zhang, Mei Ji, Zhenzhou Yang,Jiuwei Cui,Beili Gao,Buhai Wang,Hu Liu,Lei Nie, Mei He,Shi Jin,Wei Gu,Yongqian Shu,Tong Zhou,Jian Feng, Xinmei Yang,Cheng Huang,Bo Zhu,Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng,Sheng Yao, Patricia Keegan,Jie Wang

Future oncology (London, England)pp.1-8, (2024)

引用0浏览0WOS引用

Abstract CT246: Open-label, Single-Arm, Multicenter, Phase 2 Trial of Garsorasib in KRAS G12C-mutated Non-Small-cell Lung Cancer

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Development and Validation of Nomogram for Predicting the Cancer-Specific Survival among Patients Aged 80 and above with Early-Stage Non-Small Cell Lung Cancer

Qiang Guo, Yuan He, Shai Chen,Sheng Hu,Silin Wang, Lang Su,Wenxiong Zhang,Jianjun Xu,Yiping Wei, Guiping Luo

ANZ JOURNAL OF SURGERY (2024)

引用0浏览0WOS引用

Tumor Cavitation in Patients with Non-Small-cell Lung Cancer Receiving Anti-Angiogenic Therapy with Apatinib

Qian Cai,Kui Hu,Shuang Dong,Xiaoyu Li,Sheng Hu,Wenyou Deng, Wulin Ou

TRANSLATIONAL LUNG CANCER RESEARCH（2024）

引用0浏览0WOS引用

Sacituzumab Tirumotecan (SKB264/MK-2870) in Combination with KL-A167 (Anti-Pd-l1) As First-Line Treatment for Patients with Advanced NSCLC from the Phase II OptiTROP-Lung01 Study

Wenfeng Fang,Qiming Wang,Ying Cheng,Yongzhong Luo,Xiujuan Qu,Haibo Zhu,Zhenyu Ding,XingYa Li,Lin Wu,Yan Wang,Sheng Hu,Enwen Wang,Anwen Liu,Yuping Sun,Yun Fan,Feng Ye,Kaihua Lu, Yalan Yang,Junyou Ge,Li Zhang

Journal of Clinical Oncologyno. 16_suppl (2024): 8502-8502

引用0浏览0引用

Development of Prognostic Signatures and Risk Index Related to Lipid Metabolism in Ccrcc

Wenbo Chen,Zhenyu Zhao,Hao Zhou,Shuang Dong,Xiaoyu Li,Sheng Hu,Shan Zhong,Ke Chen

FRONTIERS IN ONCOLOGY (2024)

引用0浏览0WOS引用

Extracellular vesicles as modifiers of epigenomic profiles

Haifeng Zhou,Sheng Hu,Wei Yan

Trends in genetics TIGno. 9 (2024): 797-809

引用0浏览0WOS引用

KN046, a Bispecific Antibody Against PD-L1 and CTLA-4, Plus Chemotherapy As First-Line Treatment for Metastatic NSCLC: A Multicenter Phase 2 Trial

Yuanyuan Zhao,Gang Chen,Xingya Li,Jingxun Wu,Baoping Chang,Sheng Hu,Shujun Yang,Ting Xu, Yilan Liu, Ni Wang,Li Zhang,Yan Huang

CELL REPORTS MEDICINEno. 3 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn